Upload File

property rights on biodiversity and the pharmaceutical industry · 2019-09-26 · munich personal...

  • Home
  • Documents
  • Property Rights on Biodiversity and the Pharmaceutical Industry · 2019-09-26 · Munich Personal RePEc Archive Property Rights on Biodiversity and the Pharmaceutical Industry Chichilnisky,
14
Munich Personal RePEc Archive Property Rights on Biodiversity and the Pharmaceutical Industry Chichilnisky, Graciela Columbia Business School 1993 Online at https://mpra.ub.uni-muenchen.de/8330/ MPRA Paper No. 8330, posted 19 Apr 2008 04:31 UTC

Upload: others

Post on 25-Jul-2020

0 views

Category:

Documents


0 download

Report

TRANSCRIPT

Page 1: Property Rights on Biodiversity and the Pharmaceutical Industry · 2019-09-26 · Munich Personal RePEc Archive Property Rights on Biodiversity and the Pharmaceutical Industry Chichilnisky,

Munich Personal RePEc Archive

Property Rights on Biodiversity and the

Pharmaceutical Industry

Chichilnisky, Graciela

Columbia Business School

1993

Online at https://mpra.ub.uni-muenchen.de/8330/

MPRA Paper No. 8330, posted 19 Apr 2008 04:31 UTC

Page 2: Property Rights on Biodiversity and the Pharmaceutical Industry · 2019-09-26 · Munich Personal RePEc Archive Property Rights on Biodiversity and the Pharmaceutical Industry Chichilnisky,
Page 3: Property Rights on Biodiversity and the Pharmaceutical Industry · 2019-09-26 · Munich Personal RePEc Archive Property Rights on Biodiversity and the Pharmaceutical Industry Chichilnisky,
Page 4: Property Rights on Biodiversity and the Pharmaceutical Industry · 2019-09-26 · Munich Personal RePEc Archive Property Rights on Biodiversity and the Pharmaceutical Industry Chichilnisky,
Page 5: Property Rights on Biodiversity and the Pharmaceutical Industry · 2019-09-26 · Munich Personal RePEc Archive Property Rights on Biodiversity and the Pharmaceutical Industry Chichilnisky,
Page 6: Property Rights on Biodiversity and the Pharmaceutical Industry · 2019-09-26 · Munich Personal RePEc Archive Property Rights on Biodiversity and the Pharmaceutical Industry Chichilnisky,
Page 7: Property Rights on Biodiversity and the Pharmaceutical Industry · 2019-09-26 · Munich Personal RePEc Archive Property Rights on Biodiversity and the Pharmaceutical Industry Chichilnisky,
Page 8: Property Rights on Biodiversity and the Pharmaceutical Industry · 2019-09-26 · Munich Personal RePEc Archive Property Rights on Biodiversity and the Pharmaceutical Industry Chichilnisky,
Page 9: Property Rights on Biodiversity and the Pharmaceutical Industry · 2019-09-26 · Munich Personal RePEc Archive Property Rights on Biodiversity and the Pharmaceutical Industry Chichilnisky,
Page 10: Property Rights on Biodiversity and the Pharmaceutical Industry · 2019-09-26 · Munich Personal RePEc Archive Property Rights on Biodiversity and the Pharmaceutical Industry Chichilnisky,
Page 11: Property Rights on Biodiversity and the Pharmaceutical Industry · 2019-09-26 · Munich Personal RePEc Archive Property Rights on Biodiversity and the Pharmaceutical Industry Chichilnisky,
Page 12: Property Rights on Biodiversity and the Pharmaceutical Industry · 2019-09-26 · Munich Personal RePEc Archive Property Rights on Biodiversity and the Pharmaceutical Industry Chichilnisky,
Page 13: Property Rights on Biodiversity and the Pharmaceutical Industry · 2019-09-26 · Munich Personal RePEc Archive Property Rights on Biodiversity and the Pharmaceutical Industry Chichilnisky,
Page 14: Property Rights on Biodiversity and the Pharmaceutical Industry · 2019-09-26 · Munich Personal RePEc Archive Property Rights on Biodiversity and the Pharmaceutical Industry Chichilnisky,

Sustaining Biodiversity 2012. Priorities for Protecting Biodiversity Map terrestrial and aquatic biodiversity Immediately preserve biodiversity hotspots

Chapter 10 Biodiversity 10.1 What is biodiversity? 10.2 Biodiversity at risk 10.3 The future of biodiversity

Communicating Biodiversity Communicating Biodiversity

SETTING SETTING BIODIVERSITY BIODIVERSITY PRIORITIESPRIORITIES ·  · 2013-06-20SETTING SETTING BIODIVERSITY BIODIVERSITY PRIORITIESPRIORITIES ... actions for sustaining biodiversity

Air Capture & Carbon Negative Technology Economics & Engineering Graciela Chichilnisky -- Columbia University and Global Thermostat

National Biodiversity Stewardship Conference Biodiversity ...biodiversityadvisor.sanbi.org/wp-content/uploads/2017/11/1... · National Biodiversity Stewardship Conference Biodiversity

The Commercial Use of Biodiversity: Access and Benefit ... · commercial activities that policy-makers seek to regulate . Key Sectors Pharmaceutical Industrial ... Food & beverage

PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL …

Catastrophic Risks - Graciela Chichilnisky · 2017. 1. 5. · Catastrophic Risks Graciela Chichilnisky December 2008 revised July 2009 Abstract Catastrophic risks are rare events

Air Capture & Carbon Negative Technology - Graciela Chichilnisky (October 17, 2012 @ Cambridge University)

Biodiversity is life Biodiversity is our life. Biodiversity is life Biodiversity is our life

PHARMACEUTICAL ENGINEERING GUIDE Pharmaceutical

Valuing Biodiversity - IUCN · 2016. 5. 19. · Biodiversity Valuing Biodiversity The economic case for biodiversity conservation in the The economic case for biodiversity conservation

2015-2020 Seychelles’ National Biodiversity …2.1.2 Inland Waters Biodiversity 17 2.2 Marine Biodiversity 23 2.3 Key Threats to Biodiversity 37 2.4 Loss of Biodiversity 39 2.5 Biodiversity

The Green Power Fund -- A Rio+20 Presentation by Graciela Chichilnisky

Graciela Chichilnisky gives keynote speech at World Future Energy Summit in Abu Dhabi

The Green Power Fund: A Presentation from Rio+20 by Graciela Chichilnisky

The First Bi-directional Neural Network - Data Plasticitydataplasticity.com/resources/Bidirectional_JPAT__8/LaRue SSC PAC … · Graciela Chichilnisky extend the foundation of statistics

DetectionSensitivityandTemporalResolutionofVisual ...med.stanford.edu/content/dam/sm/chichilnisky/... · Baylor,1996)andvariabilityinthesingle-photonresponse(Bay- lor et al., 1979b;

Biodiversity and Technological Development: …...Brazil provides an interesting case study for the analysis of natural products and pharmaceutical development opportunities. Brazil

The Green Power Fund II: A Rio+20 Presentation by Graciela Chichilnisky

Graciela Chichilnisky

North-South Trade and the Global Environment American Economic Review Graciela Chichilnisky 1994

Air Capture & Carbon Negative Technology ™ The Global Context In the Short and the Long Run Graciela Chichilnisky - Columbia University

Air Capture & Carbon Negative Technology - Graciela Chichilnisky (October 15, 2012 @ Oxford University)

The Social Value of Using Biodiversity in New ... › doc › external › academic › pharmace... · The Social Value of Using Biodiversity in New Pharmaceutical Product Research-3-circle

Biodiversity I.What is Biodiversity? A.Levels of biodiversity B.Characterizing biodiversity C.Defining species D.How many species are there? II.Measuring

Global Environmental Risks by Graciela Chichilnisky

From the Amazon to the Alps: A Comparison of the ... · the Pharmaceutical Biodiversity Legal Protection in Brazil and Switzerland ... A Comparison of the Pharmaceutical Biodiversity

New indicators to measure Biodiversity? Comparison of ... · New indicators to measure Biodiversity? Comparison of biodiversity offset ... Biodiversity? Comparison of biodiversity

Confluence Presentation - Graciela Chichilnisky

Biodiversity. Learning Objectives Define biodiversity and explain its value. Identify current threats to biodiversity. Describe how biodiversity

Graciela Chichilnisky Columbia University May 8 2008

BIODIVERSITY EXTINCTION: 40.000 pr. YEAR!? WHAT IS BIODIVERSITY Effect of climate on biodiversity Disturbance and biodiversity The VALUE of BIODIVERSITY

KARNATAKA BIODIVERSITY BOARD Biodiversity … Volume(4...BIODIVERSITY NEWSLETTER Issue # Biodiversity Newsletter Volume-5,Issue: 4October-December2014 KARNATAKA BIODIVERSITY BOARD